The new, direct, target-specific oral anticoagulants

In recent years, numerous alternatives to VKAs have been developed, the first competitors to warfarin are the novel oral anticoagulants (NOAC) or better referred to as Direct Oral Anti-Coagulant (DOAC) or Target Specific Oral Anti-coagulant (TSOAC): These drugs have definite advantages and disadvant...

Descripció completa

Dades bibliogràfiques

Autor principal:	Nevine A Kassim
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Medknow Publications 2015-01-01
Col·lecció:	Journal of Applied Hematology
Matèries:	Direct oral anticoagulant new oral anticoagulant target specific anticoagulant
Accés en línia:	http://www.jahjournal.org/article.asp?issn=1658-5127;year=2015;volume=6;issue=4;spage=141;epage=147;aulast=Kassim
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!